Top Searches
Advertisement

PCBL Chemical Taps ₹1,000 Crore via Commercial Paper to Optimize Short-Term Funding

Updated: July 15, 2025 12:17

Image Source: ChemAnalyst
PCBL Chemical Ltd has issued and allotted commercial paper worth ₹1,000 crore (USD 120 million approx) as part of its treasury strategy to manage working capital and refinance short-term obligations. The move reflects the company’s proactive approach to liquidity management amid expansion in specialty chemicals and green energy verticals.
 
Key Highlights:
  • The commercial paper was issued on June 18, 2025, under SEBI’s Listing Obligations and Disclosure Requirements (LODR) framework.
  • Tenure and coupon rate were aligned with prevailing market conditions, targeting institutional investors through private placement.
  • Proceeds will be used to meet operational cash flow needs, refinance maturing debt, and support capex linked to the Mundra specialty chemicals facility.
Strategic Context:
  • PCBL recently commissioned Phase I of its specialty chemicals expansion and increased green power capacity to 110 MW.
  • The company has also completed the acquisition of Aquapharm Chemicals for ₹3,800 crore, diversifying its product portfolio and boosting export potential.
  • With a debt-to-equity ratio of 0.99 and EBITDA margins averaging 25.4%, PCBL maintains strong financial discipline while scaling operations.
Market Outlook:
  • Analysts view the commercial paper issuance as a low-cost funding tool that complements PCBL’s long-term capital structure.
  • The company’s share price stood at ₹359.65 as of July 15, 2025, with a 52-week high of ₹584.40, reflecting investor confidence in its growth trajectory.
Sources: Business Standard, Rediff MoneyWiz, Moneycontrol, Sharekhan, PCBL BSE Filings (July 2025)

Advertisement

STORIES YOU MAY LIKE

Image Source : Upstox
Cupid Ltd Targets Overseas Expansion with Strategic Acquisition in GII Healthcare
Image Source: Adventure Pulse
Two Climbers, Three Attempts, One Summit—India’s Everest Story Rewritten
Image Source : Free Press Joumal
Zydus Lifesciences Gets USFDA Nod For Celecoxib Capsules, Expands Pain Management Portfolio
Advertisement
Image Source : Indian Chemical News
TCL Specialties Builds Dual Chemical Plants In West Virginia Using Local Shale Gas
Image Source : ET Infra
GMR Group To Raise Rs 25,000 Crore Via Bonds As Infrastructure Push Gains Momentum
Image Source : The Tmes of India
India Ramps Up Global Alliances To Cut Reliance On China For Critical Minerals
Image Source : 24newshd
Dragon Grace Returns: SpaceX Crew With India’s Shukla Splashes Down After ISS Mission
Advertisement
Live Blogs
SBI Tags RCom Loan as Fraud, Puts Anil Ambani in RBI Crosshairs
Thrill-Seekers Assemble: APTDC Flooded with 130 Adventure Tourism Applications
Level Unlocked: Good Game Becomes World’s First As-Live Global Gaming Reality Show
From Devotion to Dynamite: Ganesh’s Mighty Avatar Steals the Show in Yours Sincerely, Raam
Top Stories
Image Source : IPO Watch
Infibeam Avenues Wraps Up Rs 700 Crore Rights Issue to Power AI and Fintech Expansion
Image Source: The Economic Times
Spandana Sphoorty Greenlights Rs 400 Crore Rights Issue to Rebuild Investor Confidence
Image Source : CAclubindia
HDFC Life Signals Strategic Shift Toward Traditional Products Amid Solid Q1 Performance
Image Source : Rattibha
Jupiter Wagons CFO Sanjiv Keshri Steps Down Amid Strategic Transition
Advertisement
Advertisement

Follow WOWNEWS 24x7 on:

Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.

Powered By Just Imagine